世界のクラドリビン市場予測 2021年-2026年

【英語タイトル】Global Cladribine Market Growth 2021-2026

LP Informationが出版した調査資料(LPI21MY9483)・商品コード:LPI21MY9483
・発行会社(調査会社):LP Information
・発行日:2021年5月(※2024年版があります。お問い合わせください)
・ページ数:160
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後2-3営業日)
・調査対象地域:グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野:医薬品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,660 ⇒換算¥541,680見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD5,490 ⇒換算¥812,520見積依頼/購入/質問フォーム
Corporate User(閲覧人数制限なし)USD7,320 ⇒換算¥1,083,360見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
LPインフォメーション社の「クラドリビンの世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、静脈内注射、皮下注射、経口錠剤など、用途別には、病院、がんセンター、その他などにセグメント区分してまとめました。クラドリビンのグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。
・クラドリビンの世界市場概要(サマリー)
・クラドリビンの企業別販売量・売上
・クラドリビンの企業別市場シェア
・クラドリビンの世界市場規模 2016年-2021年:種類別(静脈内注射、皮下注射、経口錠剤)
・クラドリビンの世界市場規模 2016年-2021年:用途別(病院、がんセンター、その他)
・クラドリビンの南北アメリカ市場規模(アメリカ、カナダ、メキシコなど)
・クラドリビンのアジア市場規模(日本、中国、韓国、インド、東南アジアなど)
・クラドリビンのヨーロッパ市場規模(ドイツ、フランス、イギリス、イタリア、ロシアなど)
・クラドリビンの中東・アフリカ市場(エジプト、南アフリカ、トルコ、GCC諸国など)
・クラドリビン市場の成長要因・課題・動向
・クラドリビンの世界市場予測 2021年-2026年
・クラドリビンの南北アメリカ市場予測(アメリカ、カナダ、メキシコなど)
・クラドリビンのアジア市場予測(日本、中国、韓国、インド、東南アジアなど)
・クラドリビンのヨーロッパ市場予測(ドイツ、フランス、イギリス、イタリア、ロシアなど)
・クラドリビンの中東・アフリカ市場予測(エジプト、南アフリカ、トルコ、GCC諸国など)
・クラドリビンの世界市場予測:種類別(静脈内注射、皮下注射、経口錠剤)
・クラドリビンの世界市場予測:用途別(病院、がんセンター、その他)
・主要企業分析
【レポートの概要】

According to this latest study, the 2021 growth of Cladribine will have significant change from previous year. By the most conservative estimates of global Cladribine market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Cladribine market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Cladribine market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Intravenous Injection
Subcutaneous Injection
Oral Tablet

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Hospital
Cancer Center
Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Fresenius Medical Care
Generic Medical Partners Inc
Johnson and Johnson
Lipomed AG
Merck KGaA
Merck and Co.
Strides Pharma Science Limited
Pfizer
Hikma Pharmaceuticals
Bedford Pharma
Zhejiang Hisun Pharmaceutical Co., Ltd.
Viatris

【レポートの目次】

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Cladribine Consumption 2016-2026
2.1.2 Cladribine Consumption CAGR by Region
2.2 Cladribine Segment by Type
2.2.1 Intravenous Injection
2.2.2 Subcutaneous Injection
2.2.3 Oral Tablet
2.3 Cladribine Sales by Type
2.3.1 Global Cladribine Sales Market Share by Type (2016-2021)
2.3.2 Global Cladribine Revenue and Market Share by Type (2016-2021)
2.3.3 Global Cladribine Sale Price by Type (2016-2021)
2.4 Cladribine Segment by Application
2.4.1 Hospital
2.4.2 Cancer Center
2.4.3 Other
2.5 Cladribine Sales by Application
2.5.1 Global Cladribine Sale Market Share by Application (2016-2021)
2.5.2 Global Cladribine Revenue and Market Share by Application (2016-2021)
2.5.3 Global Cladribine Sale Price by Application (2016-2021)

3 Global Cladribine by Company
3.1 Global Cladribine Sales Market Share by Company
3.1.1 Global Cladribine Sales by Company (2019-2021)
3.1.2 Global Cladribine Sales Market Share by Company (2019-2021)
3.2 Global Cladribine Revenue Market Share by Company
3.2.1 Global Cladribine Revenue by Company (2019-2021)
3.2.2 Global Cladribine Revenue Market Share by Company (2019-2021)
3.3 Global Cladribine Sale Price by Company
3.4 Global Manufacturers Cladribine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Cladribine Product Location Distribution
3.4.2 Players Cladribine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Cladribine by Region
4.1 Global Cladribine by Region
4.1.1 Global Cladribine Sales by Region
4.1.2 Global Cladribine Revenue by Region
4.2 Americas Cladribine Sales Growth
4.3 APAC Cladribine Sales Growth
4.4 Europe Cladribine Sales Growth
4.5 Middle East & Africa Cladribine Sales Growth

5 Americas
5.1 Americas Cladribine Sales by Country
5.1.1 Americas Cladribine Sales by Country (2016-2021)
5.1.2 Americas Cladribine Revenue by Country (2016-2021)
5.2 Americas Cladribine Sales by Type
5.3 Americas Cladribine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Cladribine Sales by Region
6.1.1 APAC Cladribine Sales by Region (2016-2021)
6.1.2 APAC Cladribine Revenue by Region (2016-2021)
6.2 APAC Cladribine Sales by Type
6.3 APAC Cladribine Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Cladribine by Country
7.1.1 Europe Cladribine Sales by Country (2016-2021)
7.1.2 Europe Cladribine Revenue by Country (2016-2021)
7.2 Europe Cladribine Sales by Type
7.3 Europe Cladribine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Cladribine by Country
8.1.1 Middle East & Africa Cladribine Sales by Country (2016-2021)
8.1.2 Middle East & Africa Cladribine Revenue by Country (2016-2021)
8.2 Middle East & Africa Cladribine Sales by Type
8.3 Middle East & Africa Cladribine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Cladribine Distributors
10.3 Cladribine Customer

11 Global Cladribine Market Forecast
11.1 Global Cladribine Forecast by Region
11.1.1 Global Cladribine Forecast by Regions (2021-2026)
11.2.2 Global Cladribine Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Country
11.3 APAC Forecast by Region
11.4 Europe Forecast by Country
11.5 Middle East & Africa Forecast by Country
11.6 Global Cladribine Forecast by Type
11.7 Global Cladribine Forecast by Application

12 Key Players Analysis
12.1 Fresenius Medical Care
12.1.1 Fresenius Medical Care Company Information
12.1.2 Fresenius Medical Care Cladribine Product Offered
12.1.3 Fresenius Medical Care Cladribine Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Fresenius Medical Care Main Business Overview
12.1.5 Fresenius Medical Care Latest Developments
12.2 Generic Medical Partners Inc
12.2.1 Generic Medical Partners Inc Company Information
12.2.2 Generic Medical Partners Inc Cladribine Product Offered
12.2.3 Generic Medical Partners Inc Cladribine Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Generic Medical Partners Inc Main Business Overview
12.2.5 Generic Medical Partners Inc Latest Developments
12.3 Johnson and Johnson
12.3.1 Johnson and Johnson Company Information
12.3.2 Johnson and Johnson Cladribine Product Offered
12.3.3 Johnson and Johnson Cladribine Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Johnson and Johnson Main Business Overview
12.3.5 Johnson and Johnson Latest Developments
12.4 Lipomed AG
12.4.1 Lipomed AG Company Information
12.4.2 Lipomed AG Cladribine Product Offered
12.4.3 Lipomed AG Cladribine Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Lipomed AG Main Business Overview
12.4.5 Lipomed AG Latest Developments
12.5 Merck KGaA
12.5.1 Merck KGaA Company Information
12.5.2 Merck KGaA Cladribine Product Offered
12.5.3 Merck KGaA Cladribine Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Merck KGaA Main Business Overview
12.5.5 Merck KGaA Latest Developments
12.6 Merck and Co.
12.6.1 Merck and Co. Company Information
12.6.2 Merck and Co. Cladribine Product Offered
12.6.3 Merck and Co. Cladribine Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Merck and Co. Main Business Overview
12.6.5 Merck and Co. Latest Developments
12.7 Strides Pharma Science Limited
12.7.1 Strides Pharma Science Limited Company Information
12.7.2 Strides Pharma Science Limited Cladribine Product Offered
12.7.3 Strides Pharma Science Limited Cladribine Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 Strides Pharma Science Limited Main Business Overview
12.7.5 Strides Pharma Science Limited Latest Developments
12.8 Pfizer
12.8.1 Pfizer Company Information
12.8.2 Pfizer Cladribine Product Offered
12.8.3 Pfizer Cladribine Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 Pfizer Main Business Overview
12.8.5 Pfizer Latest Developments
12.9 Hikma Pharmaceuticals
12.9.1 Hikma Pharmaceuticals Company Information
12.9.2 Hikma Pharmaceuticals Cladribine Product Offered
12.9.3 Hikma Pharmaceuticals Cladribine Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 Hikma Pharmaceuticals Main Business Overview
12.9.5 Hikma Pharmaceuticals Latest Developments
12.10 Bedford Pharma
12.10.1 Bedford Pharma Company Information
12.10.2 Bedford Pharma Cladribine Product Offered
12.10.3 Bedford Pharma Cladribine Sales, Revenue, Price and Gross Margin (2019-2021)
12.10.4 Bedford Pharma Main Business Overview
12.10.5 Bedford Pharma Latest Developments
12.11 Zhejiang Hisun Pharmaceutical Co., Ltd.
12.11.1 Zhejiang Hisun Pharmaceutical Co., Ltd. Company Information
12.11.2 Zhejiang Hisun Pharmaceutical Co., Ltd. Cladribine Product Offered
12.11.3 Zhejiang Hisun Pharmaceutical Co., Ltd. Cladribine Sales, Revenue, Price and Gross Margin (2019-2021)
12.11.4 Zhejiang Hisun Pharmaceutical Co., Ltd. Main Business Overview
12.11.5 Zhejiang Hisun Pharmaceutical Co., Ltd. Latest Developments
12.12 Viatris
12.12.1 Viatris Company Information
12.12.2 Viatris Cladribine Product Offered
12.12.3 Viatris Cladribine Sales, Revenue, Price and Gross Margin (2019-2021)
12.12.4 Viatris Main Business Overview
12.12.5 Viatris Latest Developments

13 Research Findings and Conclusion

List of Tables
Table 1. Cladribine Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Intravenous Injection
Table 3. Major Players of Subcutaneous Injection
Table 4. Major Players of Oral Tablet
Table 5. Global Cladribine Sales by Type (2016-2021) & (K Units)
Table 6. Global Cladribine Sales Market Share by Type (2016-2021)
Table 7. Global Cladribine Revenue by Type (2016-2021) & ($ million)
Table 8. Global Cladribine Revenue Market Share by Type (2016-2021)
Table 9. Global Cladribine Sale Price by Type (2016-2021)
Table 10. Global Cladribine Sales by Application (2016-2021) & (K Units)
Table 11. Global Cladribine Sales Market Share by Application (2016-2021)
Table 12. Global Cladribine Value by Application (2016-2021)
Table 13. Global Cladribine Revenue Market Share by Application (2016-2021)
Table 14. Global Cladribine Sale Price by Application (2016-2021)
Table 15. Global Cladribine Sales by Company (2019-2021) & (K Units)
Table 16. Global Cladribine Sales Market Share by Company (2019-2021)
Table 17. Global Cladribine Revenue by Company (2019-2021) ($ Millions)
Table 18. Global Cladribine Revenue Market Share by Company (2019-2021)
Table 19. Global Cladribine Sale Price by Company (2019-2021)
Table 20. Key Manufacturers Cladribine Producing Area Distribution and Sales Area
Table 21. Players Cladribine Products Offered
Table 22. Cladribine Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Cladribine Sales by Region (2016-2021) (K Units)
Table 26. Global Cladribine Sales Market Share by Region (2016-2021)
Table 27. Global Cladribine Revenue by Region (2016-2021) & ($ Millions)
Table 28. Global Cladribine Revenue Market Share by Region (2016-2021)
Table 29. Americas Cladribine Sales by Country (2016-2021) & (K Units)
Table 30. Americas Cladribine Sales Market Share by Country (2016-2021)
Table 31. Americas Cladribine Revenue by Country (2016-2021) & ($ Millions)
Table 32. Americas Cladribine Revenue Market Share by Country (2016-2021)
Table 33. Americas Cladribine Sales by Type (2016-2021) & (K Units)
Table 34. Americas Cladribine Sales Market Share by Type (2016-2021)
Table 35. Americas Cladribine Sales by Application (2016-2021) & (K Units)
Table 36. Americas Cladribine Sales Market Share by Application (2016-2021)
Table 37. APAC Cladribine Sales by Region (2016-2021) & (K Units)
Table 38. APAC Cladribine Sales Market Share by Region (2016-2021)
Table 39. APAC Cladribine Revenue by Region (2016-2021) & ($ Millions)
Table 40. APAC Cladribine Revenue Market Share by Region (2016-2021)
Table 41. APAC Cladribine Sales by Type (2016-2021) & (K Units)
Table 42. APAC Cladribine Sales Market Share by Type (2016-2021)
Table 43. APAC Cladribine Sales by Application (2016-2021) & (K Units)
Table 44. APAC Cladribine Sales Market Share by Application (2016-2021)
Table 45. Europe Cladribine Sales by Country (2016-2021) & (K Units)
Table 46. Europe Cladribine Sales Market Share by Country (2016-2021)
Table 47. Europe Cladribine Revenue by Country (2016-2021) & ($ Millions)
Table 48. Europe Cladribine Revenue Market Share by Country (2016-2021)
Table 49. Europe Cladribine Sales by Type (2016-2021) & (K Units)
Table 50. Europe Cladribine Sales Market Share by Type (2016-2021)
Table 51. Europe Cladribine Sales by Application (2016-2021) & (K Units)
Table 52. Europe Cladribine Sales Market Share by Application (2016-2021)
Table 53. Middle East & Africa Cladribine Sales by Country (2016-2021) & (K Units)
Table 54. Middle East & Africa Cladribine Sales Market Share by Country (2016-2021)
Table 55. Middle East & Africa Cladribine Revenue by Country (2016-2021) & ($ Millions)
Table 56. Middle East & Africa Cladribine Revenue Market Share by Country (2016-2021)
Table 57. Middle East & Africa Cladribine Sales by Type (2016-2021) & (K Units)
Table 58. Middle East & Africa Cladribine Sales Market Share by Type (2016-2021)
Table 59. Middle East & Africa Cladribine Sales by Application (2016-2021) & (K Units)
Table 60. Middle East & Africa Cladribine Sales Market Share by Application (2016-2021)
Table 61. Key and Potential Regions of Cladribine
Table 62. Key Application and Potential Industries of Cladribine
Table 63. Key Challenges of Cladribine
Table 64. Key Trends of Cladribine
Table 65. Cladribine Distributors List
Table 66. Cladribine Customer List
Table 67. Global Cladribine Sales Forecast by Region (2021-2026) & (K Units)
Table 68. Global Cladribine Consumption Market Forecast by Region
Table 69. Global Cladribine Revenue Forecast by Region (2021-2026) & ($ millions)
Table 70. Global Cladribine Revenue Market Share Forecast by Region (2021-2026)
Table 71. Americas Cladribine Sales Forecast by Country (2021-2026) & (K Units)
Table 72. Americas Cladribine Revenue Forecast by Country (2021-2026) & ($ millions)
Table 73. APAC Cladribine Sales Forecast by Region (2021-2026) & (K Units)
Table 74. APAC Cladribine Revenue Forecast by Region (2021-2026) & ($ millions)
Table 75. Europe Cladribine Sales Forecast by Country (2021-2026) & (K Units)
Table 76. Europe Cladribine Revenue Forecast by Country (2021-2026) & ($ millions)
Table 77. Middle East & Africa Cladribine Sales Forecast by Country (2021-2026) & (K Units)
Table 78. Middle East & Africa Cladribine Revenue Forecast by Country (2021-2026) & ($ millions)
Table 79. Global Cladribine Sales Forecast by Type (2021-2026) & (K Units)
Table 80. Global Cladribine Sales Market Share Forecast by Type (2021-2026)
Table 81. Global Cladribine Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 82. Global Cladribine Revenue Market Share Forecast by Type (2021-2026)
Table 83. Global Cladribine Sales Forecast by Application (2021-2026) & (K Units)
Table 84. Global Cladribine Sales Market Share Forecast by Application (2021-2026)
Table 85. Global Cladribine Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 86. Global Cladribine Revenue Market Share Forecast by Application (2021-2026)
Table 87. Fresenius Medical Care Basic Information, Cladribine Manufacturing Base, Sales Area and Its Competitors
Table 88. Fresenius Medical Care Cladribine Product Offered
Table 89. Fresenius Medical Care Cladribine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 90. Fresenius Medical Care Main Business
Table 91. Fresenius Medical Care Latest Developments
Table 92. Generic Medical Partners Inc Basic Information, Cladribine Manufacturing Base, Sales Area and Its Competitors
Table 93. Generic Medical Partners Inc Cladribine Product Offered
Table 94. Generic Medical Partners Inc Cladribine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 95. Generic Medical Partners Inc Main Business
Table 96. Generic Medical Partners Inc Latest Developments
Table 97. Johnson and Johnson Basic Information, Cladribine Manufacturing Base, Sales Area and Its Competitors
Table 98. Johnson and Johnson Cladribine Product Offered
Table 99. Johnson and Johnson Cladribine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 100. Johnson and Johnson Main Business
Table 101. Johnson and Johnson Latest Developments
Table 102. Lipomed AG Basic Information, Cladribine Manufacturing Base, Sales Area and Its Competitors
Table 103. Lipomed AG Cladribine Product Offered
Table 104. Lipomed AG Cladribine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 105. Lipomed AG Main Business
Table 106. Lipomed AG Latest Developments
Table 107. Merck KGaA Basic Information, Cladribine Manufacturing Base, Sales Area and Its Competitors
Table 108. Merck KGaA Cladribine Product Offered
Table 109. Merck KGaA Cladribine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 110. Merck KGaA Main Business
Table 111. Merck KGaA Latest Developments
Table 112. Merck and Co. Basic Information, Cladribine Manufacturing Base, Sales Area and Its Competitors
Table 113. Merck and Co. Cladribine Product Offered
Table 114. Merck and Co. Cladribine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 115. Merck and Co. Main Business
Table 116. Merck and Co. Latest Developments
Table 117. Strides Pharma Science Limited Basic Information, Cladribine Manufacturing Base, Sales Area and Its Competitors
Table 118. Strides Pharma Science Limited Cladribine Product Offered
Table 119. Strides Pharma Science Limited Cladribine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 120. Strides Pharma Science Limited Main Business
Table 121. Strides Pharma Science Limited Latest Developments
Table 122. Pfizer Basic Information, Cladribine Manufacturing Base, Sales Area and Its Competitors
Table 123. Pfizer Cladribine Product Offered
Table 124. Pfizer Cladribine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 125. Pfizer Main Business
Table 126. Pfizer Latest Developments
Table 127. Hikma Pharmaceuticals Basic Information, Cladribine Manufacturing Base, Sales Area and Its Competitors
Table 128. Hikma Pharmaceuticals Cladribine Product Offered
Table 129. Hikma Pharmaceuticals Cladribine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 130. Hikma Pharmaceuticals Main Business
Table 131. Hikma Pharmaceuticals Latest Developments
Table 132. Bedford Pharma Basic Information, Cladribine Manufacturing Base, Sales Area and Its Competitors
Table 133. Bedford Pharma Cladribine Product Offered
Table 134. Bedford Pharma Cladribine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 135. Bedford Pharma Main Business
Table 136. Bedford Pharma Latest Developments
Table 137. Zhejiang Hisun Pharmaceutical Co., Ltd. Basic Information, Cladribine Manufacturing Base, Sales Area and Its Competitors
Table 138. Zhejiang Hisun Pharmaceutical Co., Ltd. Cladribine Product Offered
Table 139. Zhejiang Hisun Pharmaceutical Co., Ltd. Cladribine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 140. Zhejiang Hisun Pharmaceutical Co., Ltd. Main Business
Table 141. Zhejiang Hisun Pharmaceutical Co., Ltd. Latest Developments
Table 142. Viatris Basic Information, Cladribine Manufacturing Base, Sales Area and Its Competitors
Table 143. Viatris Cladribine Product Offered
Table 144. Viatris Cladribine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 145. Viatris Main Business
Table 146. Viatris Latest Developments
List of Figures
Figure 1. Picture of Cladribine
Figure 2. Cladribine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Cladribine Sales Growth Rate 2016-2026 (K Units)
Figure 7. Global Cladribine Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Cladribine Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Intravenous Injection
Figure 10. Product Picture of Subcutaneous Injection
Figure 11. Product Picture of Oral Tablet
Figure 12. Global Cladribine Sales Market Share by Type in 2020
Figure 13. Global Cladribine Revenue Market Share by Type (2016-2021)
Figure 14. Cladribine Consumed in Hospital
Figure 15. Global Cladribine Market: Hospital (2016-2021) & (K Units)
Figure 16. Cladribine Consumed in Cancer Center
Figure 17. Global Cladribine Market: Cancer Center (2016-2021) & (K Units)
Figure 18. Cladribine Consumed in Other
Figure 19. Global Cladribine Market: Other (2016-2021) & (K Units)
Figure 20. Global Cladribine Sales Market Share by Application (2016-2021)
Figure 21. Global Cladribine Revenue Market Share by Application in 2020
Figure 22. Cladribine Revenue Market by Company in 2020 ($ Million)
Figure 23. Global Cladribine Revenue Market Share by Company in 2020
Figure 24. Global Cladribine Sales Market Share by Regions (2016-2021)
Figure 25. Global Cladribine Revenue Market Share by Region in 2020
Figure 26. Americas Cladribine Sales 2016-2021 (K Units)
Figure 27. Americas Cladribine Revenue 2016-2021 ($ Millions)
Figure 28. APAC Cladribine Sales 2016-2021 (K Units)
Figure 29. APAC Cladribine Revenue 2016-2021 ($ Millions)
Figure 30. Europe Cladribine Sales 2016-2021 (K Units)
Figure 31. Europe Cladribine Revenue 2016-2021 ($ Millions)
Figure 32. Middle East & Africa Cladribine Sales 2016-2021 (K Units)
Figure 33. Middle East & Africa Cladribine Revenue 2016-2021 ($ Millions)
Figure 34. Americas Cladribine Sales Market Share by Country in 2020
Figure 35. Americas Cladribine Revenue Market Share by Country in 2020
Figure 36. Americas Cladribine Sales Market Share by Type in 2020
Figure 37. Americas Cladribine Sales Market Share by Application in 2020
Figure 38. United States Cladribine Revenue Growth 2016-2021 ($ Millions)
Figure 39. Canada Cladribine Revenue Growth 2016-2021 ($ Millions)
Figure 40. Mexico Cladribine Revenue Growth 2016-2021 ($ Millions)
Figure 41. Brazil Cladribine Revenue Growth 2016-2021 ($ Millions)
Figure 42. APAC Cladribine Sales Market Share by Region in 2020
Figure 43. APAC Cladribine Revenue Market Share by Regions in 2020
Figure 44. APAC Cladribine Sales Market Share by Type in 2020
Figure 45. APAC Cladribine Sales Market Share by Application in 2020
Figure 46. China Cladribine Revenue Growth 2016-2021 ($ Millions)
Figure 47. Japan Cladribine Revenue Growth 2016-2021 ($ Millions)
Figure 48. Korea Cladribine Revenue Growth 2016-2021 ($ Millions)
Figure 49. Southeast Asia Cladribine Revenue Growth 2016-2021 ($ Millions)
Figure 50. India Cladribine Revenue Growth 2016-2021 ($ Millions)
Figure 51. Australia Cladribine Revenue Growth 2016-2021 ($ Millions)
Figure 52. Europe Cladribine Sales Market Share by Country in 2020
Figure 53. Europe Cladribine Revenue Market Share by Country in 2020
Figure 54. Europe Cladribine Sales Market Share by Type in 2020
Figure 55. Europe Cladribine Sales Market Share by Application in 2020
Figure 56. Germany Cladribine Revenue Growth 2016-2021 ($ Millions)
Figure 57. France Cladribine Revenue Growth 2016-2021 ($ Millions)
Figure 58. UK Cladribine Revenue Growth 2016-2021 ($ Millions)
Figure 59. Italy Cladribine Revenue Growth 2016-2021 ($ Millions)
Figure 60. Russia Cladribine Revenue Growth 2016-2021 ($ Millions)
Figure 61. Middle East & Africa Cladribine Sales Market Share by Country in 2020
Figure 62. Middle East & Africa Cladribine Revenue Market Share by Country in 2020
Figure 63. Middle East & Africa Cladribine Sales Market Share by Type in 2020
Figure 64. Middle East & Africa Cladribine Sales Market Share by Application in 2020
Figure 65. Egypt Cladribine Revenue Growth 2016-2021 ($ Millions)
Figure 66. South Africa Cladribine Revenue Growth 2016-2021 ($ Millions)
Figure 67. Israel Cladribine Revenue Growth 2016-2021 ($ Millions)
Figure 68. Turkey Cladribine Revenue Growth 2016-2021 ($ Millions)
Figure 69. GCC Country Cladribine Revenue Growth 2016-2021 ($ Millions)
Figure 70. Channels of Distribution
Figure 71. Distributors Profiles


★調査レポート[世界のクラドリビン市場予測 2021年-2026年] (コード:LPI21MY9483)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のクラドリビン市場予測 2021年-2026年]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆